IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30

$0.57+0.02 (+2.75%)

Close on Nov 13, 2026Market cap $3.35MP/E –Yield –

IM Cannabis r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2020 it was C$136.00K, down 41.6% from the year before.

Period	Period end	Value	Change
FY2020	Dec 31, 2020	C$136.00K	-41.6%
FY2019	Dec 31, 2019	C$233.00K	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMCC.

Revenue growth1.3% · median 33.2%

Gross margin17.7% · median 35.5%

Operating margin-21.2% · median -25.4%

Net margin-20.7% · median -29.5%

Advertisement
300 × 250

See a number that looks wrong?